XLXiaoyan Li

Xiaoyan Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaoyan Li has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessing Hospital Infrastructure Resilience in Pandemics

    by Xiaoyan Li, Ange Lin

    In the era of globalization, infectious diseases pose a significant threat to global health and societal stability. They strain healthcare systems, necessitating robust preventive strategies, particularly in creating resilient hospital environments. Our study identifies and analyzes hospital environmental safety risk factors during pandemics, emphasizing the need for context-specific risk mitigation. By integrating literature review with linguistic assessment of risk factors, we reveal complex hospital safety dimensions and underappreciated epidemiological risks. Using triangular fuzzy number theory and the DEMATEL method, we develop an evaluation model that quantifies hospital environment risks and their interdependencies, enhancing informed decision-making for epidemic prevention and resource allocation, contributing to healthcare infrastructure sustainability and societal well-being.


  • Open Access

    Nano-carrier DMSN for effective multi-antigen vaccination against SARS-CoV-2

    by Peng Sun, Bingsheng Cheng, Jiaxi Ru, Xiaoyan Li, Guicun Fang, Yinli Xie, Guangjiang Shi, Jichao Hou, Longwei Zhao, Lipeng Gan, et al.

    The pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has had a profound impact on the global health and economy. While mass vaccination for herd immunity is effective, emerging SARS-CoV-2 variants can evade spike protein-based COVID-19 vaccines. In this study, we develop a new immunization strategy by utilizing a nanocarrier, dendritic mesoporous silica nanoparticle (DMSN), to deliver the receptor-binding domain (RBD) and conserved T-cell epitope peptides (DMSN-P-R), aiming to activate both humoral and cellular immune responses in the host. The synthesized DMSN had good uniformity and dispersion and showed a strong ability to load the RBD and peptide antigens, enhancing their uptake by antigen-presenting cells (APCs) and promoting antigen delivery to lymph nodes. The DMSN-P-R vaccine elicited potent humoral immunity, characterized by highly specific RBD antibodies. Neutralization tests demonstrated significant antibody-mediated neutralizing activity against live SARS-CoV-2. Crucially, the DMSN-P-R vaccine also induced robust T-cell responses that were specifically stimulated by the RBD and conserved T-cell epitope peptides of SARS-CoV-2. The DMSN demonstrated excellent biocompatibility and biosafety in vitro and in vivo, along with degradability. Our study introduces a promising vaccine strategy that utilizes nanocarriers to deliver a range of antigens, effectively enhancing both humoral and cellular immune responses to prevent virus transmission.


  • Open Access

    Anti-infection effects of heparin on SARS-CoV-2 in a diabetic mouse model

    by Zhongyun Zhang, Ning Zhang, Xuancheng Lu, Min Zhou, Xiaoxiang Yan, Weiqiong Gu, Jingru Yang, Qin Zhang, Cheng Zhang, Yuhuan Gong, et al.

    SARS-CoV-2 infection has been shown to result in more severe syndromes and poorer outcomes in patients with diabetes and obesity, as compared to those without these conditions. The underlying mechanisms responsible for the combined impact of COVID-19 and diabetes are not yet fully elucidated, and effective treatment options for SARS-CoV-2 infections in diabetic patients are currently limited. To investigate the pathogenesis of 9These two mouse models were intranasally infected with 5 × 105 TCID50 SARS-CoV-2, sera and lung tissues were collected 3 days post-infection. Then, hACE2Tg-db/db mice were administered a combination of low-molecular-weight heparin (LMWH) (1mg/Kg or 5 mg/Kg) and insulin via subcutaneous injection prior to intranasal infection with 1 × 104 TCID50 SARS-CoV-2. Daily drug administration continued until the euthanasia of the mice. Analysis of viral RNA loads, histopathological changes in lung tissue, and inflammation factors was conducted. Results demonstrated similar susceptibility of hACE2Tg mice in both lean (chow diet) status and obesity (HFD) status. However, compared to the hACE2Tg-WT mice, hACE2Tg-db/db mice exhibited more severe lung injury, increased expression of inflammatory cytokines and hypoxia-inducible factor (HIF)-1α, and enhanced apoptosis. Moreover, the combination treatment of LMWH and insulin was found to effectively reduce disease progression and severity, attenuate lung pathological changes, and mitigate inflammatory responses. In conclusion, pre-existing diabetes can lead to more severe lung damage upon SARS-CoV-2 infection, and LMWH might be a valuable therapeutic approach for managing COVID-19 patients with diabetes.


  • Open Access

    Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods

    by Shengman Yu, Xiaoyan Li, Zhuoyuan Xin, Liyuan Sun, Jingwei Shi

    At the end of 2019, the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, seriously damaged world public health security. Several protein markers associated with virus infection have been extensively explored to combat the ever-increasing challenge posed by SARS-CoV-2. The proteomics of COVID-19 deepened our understanding of viral particles and their mechanisms of host invasion, providing us with information on protein changes in host tissues, cells and body fluids following infection in COVID-19 patients. In this review, we summarize the proteomic studies of SARS-CoV-2 infection and review the current understanding of COVID-19 in terms of the quantitative and qualitative proteomics of viral particles and host entry factors from the perspective of protein pathological changes in the organism following host infection.


  • Relationship between sexual sensation seeking and condom use among young men who have sex with men in China: testing a moderated mediation model

    by Wei Wang, Hong Yan, Zhizhou Duan, Huiming Yang, Xiaoyan Li, Changmian Ding, Shumin Deng, Shiyue Li

    The present study incorporated a moderated mediation model to explore the role of attitude towards condom use in mediating the link between sexual sensation seeking (SSS) and condom use and whether this indirect link was modified by HIV-related knowledge among Chinese YMSM. Survey data were collected from a cross-sectional study conducted in Wuhan, China and 373 YMSM were recruited. The mediation and moderated mediation modelling analyses were performed with the software SPSS PROCESS macro. Mediation analysis indicated that attitude towards condom use partly mediated the link between SSS and condom use (indict effect = −0.158, P < 0.001). Moderation analysis found HIV-related knowledge acted as a moderator in the relationship between SSS and attitude towards condom use (interact effect = 0.089, P = 0.001). Final moderated mediation analysis demonstrated that the indirect effect from SSS to condom use through attitude towards condom use was moderated by HIV-related knowledge, that is the interaction between HIV-related knowledge and SSS was positively associated with attitude towards condom use (β = 0.101, P < 0.001). Therefore, increased YMSM-specific HIV-related knowledge education programs need to be conducted. Further longitudinal research is required to verify the findings of this study.


  • Open Access

    A Case of COVID-19 — Tianjin Municipality, China, November 7, 2020

    by Tianjin Tianjin Center For Disease Control And Prevention, Laboratory Testing Group, Yang Song, Xiang Zhao, Xiaoyan Li, Wenbo Xu, COVID-19 Field Response Group